Skip to main content
MCRB logo
MCRB
(NASDAQ)
Seres Therapeutics, Inc.
$5.23-- (--)
Loading... - Market loading

Seres Therapeutics (MCRB) Stock Price & Financial Analysis

Seres Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.11 - $5.36
52-Week High$29.98
52-Week Low$5.00
Open$5.21
Volume29.81K
Average Volume (3M)114.44K
Market Cap50.12M
Shares Outstanding9.58M
Price to Sales (P/S)33.46
Price to Book (P/B)1.89
EV/EBITDA4.61
Revenue (TTM)1.50M
Net Income (TTM)-46.90M
Free Cash Flow (TTM)-42.37M
EPS (TTM)$-5.22
Profit Margin-3130.77%
Operating Margin-5850.60%
Return on Equity (ROE)-176.98%
Debt to Equity3.04
50-Day MA$6.82
200-Day MA$11.70
52-Week Change-60.05%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Seres Therapeutics

What is the current stock price for MCRB?

As of the latest trading session, MCRB stock trades at $5.23. The 52-week range is $5.00–$29.98, with a day range of $5.11–$5.36.

What is the P/E ratio for MCRB?

The P/E ratio (Price-to-Earnings) for MCRB is shown in the Key Statistics section. This valuation metric helps compare Seres Therapeutics, Inc. to industry peers.

Does MCRB pay dividends?

Seres Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MCRB?

Analyst ratings and recommendations for MCRB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of MCRB?

Seres Therapeutics's market capitalization is $50.1M, classifying it as a micro-cap company. Seres Therapeutics operates in the Healthcare sector within the Biotechnology industry.